LivsMed리브스메드
491000 · KOSDAQ · ₩491000 · 리브스메드
₩39,400▼ ₩1,050 (2.60%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | |
|---|---|---|
| Revenue | ₩13B | ₩10B |
| Cost of sales | ₩7.1B | ₩5.8B |
| Gross profit | ₩5.4B | ₩4.5B |
| Operating income | −₩12B | −₩8.4B |
| Net income | −₩5.2B | −₩5.9B |
| Net income to shareholders | −₩11B | −₩5.9B |
Balance sheet
| Q2 2026 | Q1 2026 | |
|---|---|---|
| Total assets | ₩188B | ₩198B |
| Current assets | ₩117B | ₩168B |
| Cash and equivalents | ₩51B | ₩16B |
| Total liabilities | ₩24B | ₩23B |
| Current liabilities | ₩15B | ₩15B |
| Borrowings | ₩3B | ₩3B |
| Total equity | ₩164B | ₩175B |
| Shareholders' equity | ₩164B | ₩175B |
Cash flow
| Q2 2026 | Q1 2026 | |
|---|---|---|
| Cash from operations | −₩18B | −₩13B |
| Capital spending | ₩32B | ₩1.7B |
| Free cash flow | −₩49B | −₩15B |
Consolidated where available. Amounts in won.
Also known as: LivsMed / 리브스메드 / 491000 / KRX:491000
Source: KRX statistical information